Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) in Participants 9 Through 49 Years of Age.

ClinicalTrials.gov ID: NCT05513053

Public ClinicalTrials.gov record NCT05513053. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 4:35 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) in Children and Adolescents Aged 9 to 17 Years and Adults Aged 18 to 49 Years.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study was to demonstrate the non-inferiority (NI) of the HAI immune response of RIV4 in participants aged 9 to 17 years vs participants aged 18 to 49 years and to describe the immunogenicity and safety profile of RIV4 in all participants.

Study identification

NCT ID
NCT05513053
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
1,308 participants

Conditions and interventions

Eligibility (public fields only)

Age range
9 Years to 49 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 27, 2022 (Actual)
Primary completion
Oct 27, 2023 (Actual)
Completion
Oct 27, 2023 (Actual)
Last update posted
Sep 9, 2025

2022 – 2023

United States locations

U.S. sites
21
U.S. states
14
U.S. cities
19
Facility City State ZIP Site status
Alabama Clinical Therapeutics North Tower Site Number : 8400024 Birmingham Alabama 35205 —
Birmingham Pediatric Associates Site Number : 8400023 Birmingham Alabama 35205 —
The Children's Clinic Of Jonesboro PA Site Number : 8400025 Jonesboro Arkansas 72401 —
California Research Foundation Site Number : 8400003 San Diego California 92123-1881 —
Meridian Clinical Research- Sioux City Site Number : 8400007 Sioux City Iowa 51106 —
AMR - Newton Site Number : 8400021 Newton Kansas 67114 —
Kentucky Pediatics / Adult Research Site Number : 8400010 Bardstown Kentucky 40004 —
Velocity Clinical Research Site Number : 8400012 New Orleans Louisiana 70119 —
Velocity Clinical Research Lincoln Site Number : 8400013 Lincoln Nebraska 68510 —
Meridian Clinical Research Norfolk Site Number : 8400011 Norfolk Nebraska 68701 —
Velocity Clinical Research, Omaha Site Number : 8400009 Omaha Nebraska 68134 —
Meridian Clinical Research Site Number : 8400006 Binghamton New York 13905 —
Velocity Clinical Research Vestal Site Number : 8400016 Vestal New York 13850 —
Ohio Pediatric Research Site Number : 8400020 Dayton Ohio 45414 —
Rainbow Pediatrics Site Number : 8400014 Barnwell South Carolina 29812 —
Coastal Pediatric Research Charleston Site Number : 8400005 Charleston South Carolina 29414 —
Coastal Carolina Research Center - N Charleston Site Number : 8400022 North Charleston South Carolina 29405 —
Benchmark Research - Austin Site Number : 8400004 Austin Texas 78705 —
JBR Clinical Research Site Number : 8400001 Salt Lake City Utah 84107 —
J. Lewis Research Site Number : 8400017 Salt Lake City Utah 84109 —
Velocity Clinical Research Portsmouth Site Number : 8400015 Portsmouth Virginia 23703 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05513053, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 9, 2025 · Synced Nov 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05513053 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →